April 2, 2019 /

Italfarmaco Provides Givinostat Update (March 2019)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Italfarmaco Provides Givinostat Update (March 2019)

Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List